Technical factors in lower-extremity vein bypass surgery: how can we improve outcomes?
- PMID: 20006802
- DOI: 10.1053/j.semvascsurg.2009.10.004
Technical factors in lower-extremity vein bypass surgery: how can we improve outcomes?
Abstract
Lower-extremity vein bypass surgery has been a standard operation in the armamentarium of vascular surgeons for more than 4 decades. Yet there remains surprising heterogeneity in the utilization, techniques, and outcomes associated with this procedure in current practice. Despite improvements in surgical technique and careful postoperative surveillance, vein graft failure remains a significant clinical problem affecting up to 50% of patients within 5 years. Experience, clinical judgment, creativity, and technical precision are required to optimize long-term results. Many factors, including patient-specific comorbidities, and variable biologic responses in the venous conduit, influence the ultimate outcome. Technical factors, however, play a dominant role in determining clinical success. Multiple single-center reports, and more recent multicenter trials, have clearly demonstrated that conduit selection and quality is the most critical element. An adequate caliber (>/=3.5 mm), good quality great saphenous vein is the optimal graft for infrainguinal bypass. Contralateral great saphenous vein, arm vein, and lesser saphenous vein are the next most desirable conduits. Graft configuration (reversed, nonreversed, or in situ) appears to have little influence on outcomes per se. Shorter grafts have improved patency. Inflow can be improved by surgical or endovascular means if necessary, and distal-origin grafts perform as well as those originating from the common femoral artery. The selected outflow vessel should supply unimpeded runoff to the foot, conserve conduit length, and allow for adequate soft-tissue coverage of the graft and a simplified surgical exposure. This review summarizes the data linking technical factors with graft patency, highlighting the importance of surgical judgment and operative planning in the current practice of infrainguinal bypass surgery.
Similar articles
-
Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and outcomes.J Vasc Surg. 2010 Sep;52(3 Suppl):96S-103S. doi: 10.1016/j.jvs.2010.06.015. J Vasc Surg. 2010. PMID: 20804940 Review.
-
Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and outcomes.J Am Podiatr Med Assoc. 2010 Sep-Oct;100(5):429-38. doi: 10.7547/1000429. J Am Podiatr Med Assoc. 2010. PMID: 20847358 Review.
-
Technical modifications in endoscopic vein harvest techniques facilitate their use in lower extremity limb salvage procedures.J Vasc Surg. 2007 Mar;45(3):549-53. doi: 10.1016/j.jvs.2006.10.050. Epub 2007 Jan 31. J Vasc Surg. 2007. PMID: 17275245
-
Increased warm ischemia time during vessel harvest decreases the primary patency of cryopreserved conduits in patients undergoing lower extremity bypass.J Vasc Surg. 2019 Jan;69(1):164-173. doi: 10.1016/j.jvs.2018.04.065. Epub 2018 Aug 17. J Vasc Surg. 2019. PMID: 30126787 Free PMC article.
-
Surgical management of critical limb ischemia.Tech Vasc Interv Radiol. 2005 Dec;8(4):169-74. doi: 10.1053/j.tvir.2006.04.004. Tech Vasc Interv Radiol. 2005. PMID: 16849097 Review.
Cited by
-
Detrimental effects of mechanical stretch on smooth muscle function in saphenous veins.J Vasc Surg. 2011 Feb;53(2):454-60. doi: 10.1016/j.jvs.2010.09.010. Epub 2010 Dec 13. J Vasc Surg. 2011. PMID: 21146345 Free PMC article.
-
Circulating inflammatory cells are associated with vein graft stenosis.J Vasc Surg. 2011 Oct;54(4):1124-30. doi: 10.1016/j.jvs.2011.04.039. Epub 2011 Sep 9. J Vasc Surg. 2011. PMID: 21906902 Free PMC article.
-
Brilliant blue FCF is a nontoxic dye for saphenous vein graft marking that abrogates response to injury.J Vasc Surg. 2016 Jul;64(1):210-8. doi: 10.1016/j.jvs.2014.12.059. Epub 2015 Feb 19. J Vasc Surg. 2016. PMID: 25704409 Free PMC article.
-
Heparin-functionalized polymer graft surface eluting MK2 inhibitory peptide to improve hemocompatibility and anti-neointimal activity.J Control Release. 2017 Nov 28;266:321-330. doi: 10.1016/j.jconrel.2017.10.002. Epub 2017 Oct 4. J Control Release. 2017. PMID: 28987880 Free PMC article.
-
Ephrin type-B receptor 4 activation reduces neointimal hyperplasia in human saphenous vein in vitro.J Vasc Surg. 2016 Mar;63(3):795-804. doi: 10.1016/j.jvs.2014.09.036. Epub 2014 Oct 24. J Vasc Surg. 2016. PMID: 25446283 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical